Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2009-05-14 23:15 | 2009-05-14 | SYK | STRYKER CORP | COX HOWARD E JR | Director | SELL | $39.34 | 20,000 | $786,776 | 584,732 |
| 2009-05-15 02:16 | 2009-05-12 | DCTH | DELCATH SYSTEMS, INC. | Keck Barbra | Officer | BUY | $3.24 | 1,000 | $3,240 | 1,000 |
| 2009-05-14 22:27 | 2009-05-12 | STEM | Microbot Medical Inc. | KOSHY GEORGE | OPT+S | $1.70 | 10,000 | $17,000 | 70,000 | |
| 2009-05-14 23:07 | 2009-05-13 | DXCM | DEXCOM INC | GREGG TERRANCE H | Director, Officer | BUY | $3.74 | 20,000 | $74,896 | 463,013 |
| 2009-05-14 23:04 | 2009-05-12 | DXCM | DEXCOM INC | VALDES JORGE A | Officer | BUY | $3.75 | 5,000 | $18,767 | 19,638 |
| 2009-05-13 23:02 | 2009-05-11 | BSX | BOSTON SCIENTIFIC CORP | ABELE JOHN E | Director | SELL | $9.19 | 200,000 | $1,838,600 | 23,222,530 |
| 2009-05-13 20:45 | 2009-05-11 | UTMD | UTAH MEDICAL PRODUCTS INC | Beeson James H | Director | BUY | $22.06 | 400 | $8,824 | 400 |
| 2009-05-13 23:40 | 2009-05-11 | RMD | RESMED INC | Gallahue Kieran | Director, Officer | OPT+S | $40.00 | 5,000 | $200,000 | 3,224 |
| 2009-05-13 22:54 | 2009-05-12 | BVX | Apyx Medical Corporation | SARON J ROBERT | Director, Officer | SELL | $7.33 | 15,000 | $109,950 | 387,319 |
| 2009-05-13 22:37 | 2009-05-12 | BVX | Apyx Medical Corporation | CITRONOWICZ MOSHE | Officer | SELL | $7.45 | 13,500 | $100,575 | 406,504 |
| 2009-05-13 23:37 | 2009-05-11 | RMD | RESMED INC | PACE GARY W | Director | OPT+S | $39.95 | 10,666 | $426,132 | 157,500 |
| 2009-05-13 23:02 | 2009-05-11 | BSX | BOSTON SCIENTIFIC CORP | PEPPER JOHN E | Director | BUY | $9.18 | 6,000 | $55,080 | 58,807 |
| 2009-05-12 20:51 | 2009-05-08 | RMD | RESMED INC | FARRELL PETER C | Director, Officer | SELL | $40.08 | 5,000 | $200,400 | 807,672 |
| 2009-05-11 23:09 | 2009-05-07 | BSX | BOSTON SCIENTIFIC CORP | ABELE JOHN E | Director | SELL | $9.04 | 200,000 | $1,807,900 | 23,422,530 |
| 2009-05-12 03:03 | 2009-05-07 | CYTX | PLUS THERAPEUTICS, INC. | RICKEY DAVID | Director | BUY | $2.28 | 4,386 | $10,000 | 13,235 |
| 2009-05-12 03:02 | 2009-05-07 | CYTX | PLUS THERAPEUTICS, INC. | HENRIKSEN RONALD D | Director | BUY | $2.28 | 22,000 | $50,160 | 50,524 |
| 2009-05-12 03:01 | 2009-05-07 | CYTX | PLUS THERAPEUTICS, INC. | HEDRICK MARC H | Director, Officer | BUY | $2.28 | 20,000 | $45,600 | 448,238 |
| 2009-05-08 23:07 | 2009-05-06 | BSX | BOSTON SCIENTIFIC CORP | PEPPER JOHN E | Director | BUY | $8.60 | 6,000 | $51,600 | 52,807 |
| 2009-05-07 23:21 | 2009-05-05 | BSX | BOSTON SCIENTIFIC CORP | ABELE JOHN E | Director | SELL | $8.49 | 200,000 | $1,698,400 | 23,622,530 |
| 2009-05-08 00:37 | 2009-05-01 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | Officer | BUY | $43.89 | 277 | $12,156 | 6,658 |
| 2009-05-07 23:55 | 2009-05-07 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $41.15 | 20,000 | $823,086 | 18,936,682 |
| 2009-05-07 17:37 | 2009-05-06 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $40.46 | 60,000 | $2,427,486 | 18,956,682 |
| 2009-05-07 23:21 | 2009-05-06 | BSX | BOSTON SCIENTIFIC CORP | MARIO ERNEST | Director | BUY | $8.49 | 50,000 | $424,650 | 71,004 |
| 2009-05-06 23:57 | 2009-05-04 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | Director, Officer | SELL | $53.70 | 799 | $42,906 | 22,193 |
| 2009-05-06 03:46 | 2009-05-01 | HAE | HAEMONETICS CORP | ALLEN PETER M | Officer | BUY | $43.89 | 308 | $13,517 | 6,616 |
| 2009-05-06 03:22 | 2009-05-01 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | Director, Officer | BUY | $43.89 | 424 | $18,607 | 22,992 |
| 2009-05-06 03:23 | 2009-05-01 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | Officer | BUY | $43.89 | 424 | $18,607 | 3,339 |
| 2009-05-06 03:24 | 2009-05-01 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | Officer | BUY | $43.89 | 347 | $15,228 | 30,264 |
| 2009-05-06 03:23 | 2009-05-01 | HAE | HAEMONETICS CORP | EBBELING ROBERT B | Officer | BUY | $43.89 | 424 | $18,607 | 15,849 |
| 2009-05-06 03:23 | 2009-05-01 | HAE | HAEMONETICS CORP | HANLON SUSAN M | Officer | BUY | $43.89 | 152 | $6,671 | 4,660 |
| 2009-05-01 18:57 | 2009-04-17 | ANGO | Angiodynamics Inc. | Orsatti Charles Thomas | Director | BUY | $12.00 | 2,000 | $24,000 | 2,000 |
| 2009-04-30 18:28 | 2009-04-24 | PDEX | PRO DEX INC | COSS RONALD G | 10% owner | SELL | $0.40 | 40,000 | $16,000 | 1,226,879 |
| 2009-05-01 00:43 | 2009-04-30 | SYK | STRYKER CORP | LANCE HOWARD L | Director | BUY | $38.67 | 3,000 | $116,001 | 3,000 |
| 2009-04-30 20:51 | 2009-04-28 | SYK | STRYKER CORP | FRANCESCONI LOUISE | Director | BUY | $38.40 | 5,000 | $192,000 | 10,000 |
| 2009-04-23 23:11 | 2009-04-21 | BSX | BOSTON SCIENTIFIC CORP | ABELE JOHN E | Director | SELL | $8.55 | 300,000 | $2,566,200 | 23,808,029 |
| 2009-04-21 23:05 | 2009-04-17 | BSX | BOSTON SCIENTIFIC CORP | ABELE JOHN E | Director | SELL | $8.87 | 300,000 | $2,660,400 | 24,108,029 |
| 2009-04-17 23:03 | 2009-04-15 | BSX | BOSTON SCIENTIFIC CORP | ABELE JOHN E | Director | SELL | $9.00 | 300,000 | $2,700,600 | 24,408,029 |
| 2009-04-17 18:49 | 2009-04-15 | BVX | Apyx Medical Corporation | CITRONOWICZ MOSHE | Officer | SELL | $7.06 | 6,500 | $45,890 | 420,004 |
| 2009-04-18 01:02 | 2009-04-16 | STEM | Microbot Medical Inc. | WEISSMAN IRVING | Director | SELL | $1.70 | 50,000 | $85,000 | 483,736 |
| 2009-04-15 23:09 | 2009-04-13 | BSX | BOSTON SCIENTIFIC CORP | ABELE JOHN E | Director | SELL | $8.90 | 300,000 | $2,668,650 | 24,708,029 |
| 2009-04-14 18:55 | 2009-02-11 | ANGO | Angiodynamics Inc. | Keltjens Jan | Officer | BUY | $12.73 | 10,000 | $127,331 | 10,000 |
| 2009-04-14 22:53 | 2009-04-13 | MELA | STRATA Skin Sciences, Inc. | Lufkin Dan W | Director | BUY | $6.08 | 2,500 | $15,204 | 12,500 |
| 2009-04-13 23:16 | 2009-04-09 | BSX | BOSTON SCIENTIFIC CORP | ABELE JOHN E | Director | SELL | $8.88 | 150,000 | $1,332,000 | 25,008,029 |
| 2009-04-13 21:56 | 2009-04-08 | BVX | Apyx Medical Corporation | CITRONOWICZ MOSHE | Officer | SELL | $6.33 | 40,000 | $253,032 | 426,504 |
| 2009-04-09 20:34 | 2009-04-07 | BSX | BOSTON SCIENTIFIC CORP | ABELE JOHN E | Director | SELL | $8.46 | 300,000 | $2,536,500 | 25,158,029 |
| 2009-04-09 04:20 | 2009-03-23 | ATEC | Alphatec Holdings, Inc. | Molson R Ian | Director | BUY | $1.27 | 71,800 | $91,164 | 125,937 |
| 2009-04-09 04:20 | 2009-03-12 | ATEC | Alphatec Holdings, Inc. | Hochschuler Stephen | Director | BUY | $1.23 | 30,000 | $36,810 | 132,183 |
| 2009-04-09 04:19 | 2009-03-04 | ATEC | Alphatec Holdings, Inc. | Hochschuler Stephen | Director | BUY | $1.65 | 20,000 | $33,000 | 102,183 |
| 2009-04-08 19:52 | 2009-04-06 | BVX | Apyx Medical Corporation | SARON J ROBERT | Director, Officer | SELL | $6.34 | 15,700 | $99,560 | 402,319 |
| 2009-04-08 21:08 | 2009-04-07 | STEM | Microbot Medical Inc. | KOSHY GEORGE | OPT+S | $1.61 | 10,000 | $16,100 | 70,000 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.